Endoron Medical News
3 articles
growth-positive
Endoron Medical Raises $10M in Series A Funding
Endoron Medical, a medtech company based in Tel Aviv, has raised $10M in Series A funding. The funding round was led by Sofinnova Partners, with participation from the European Innovation Council Fund. Endoron Medical specializes in endograft stapling solutions for the endovascular repair of abdominal aortic aneurysms. The company plans to use the funds to accelerate the clinical validation of its flagship product, the catheter-based EndoStapling solution Aortoseal, as it progresses through its Investigational Device Exemption approved Early Feasibility Study.
Investment
growth-positive
Israeli start-up seals the deal...
Israeli MedTech start-up, Endoron Medical, has raised $5 million in a seed round led by the Sofinnova Partners Acceleration Fund. The funding will be used to accelerate the development of the companys technology for endovascular repair of abdominal aortic aneurysms. Endoron Medical has developed a unique endograft stapling solution that overcomes challenges associated with sealing and fixation of endografts in complex anatomies. The technology mimics the reliable hand-sewn suturing technique from open surgery, creating a leak and migration-free anastomosis. The funds will be used to validate the safety, feasibility, and efficacy of the companys patented endovascular suturing technology. Endoron Medical was founded in 2019 and has raised a total of $5 million in seed funding.
Investment
Sofinnova Partners Announces a New Investment From Its Medtech Acceleration Fund
